NCS Multistage Stock Rises Despite Profit Reversal - But the Headline Has It Backwards

The "NCS Multistage stock rises despite profit reversal" headline gets the cause and effect wrong. The profit reversal is a distraction, and the rise has nothing to do with investor confidence in NCS as a going standalone business. NCS Multistage Holdings is being acquired by Weatherford International, and the stock has moved from roughly $29 before the deal was announced in early June to $47 today - a 62% jump - because it is trading toward a merger price, not because the market has rediscovered its earnings power.

The Q2 2026 report card reads worse than it is at the GAAP level but worse for different reasons beneath the surface. Revenue came in at $38.4 million, up 5% year over year and slightly above the $38 million consensus estimate. Gross profit was $13.1 million, with a 34% margin that held steady against the year-ago quarter. Adjusted EBITDA - earnings before interest, taxes, depreciation, and amortization, the closest proxy to the cash the business generates from operations - was $1.9 million, down from $2.2 million a year ago. That's a modest decline, not a collapse.

The headline loss, though, is ugly: $4.6 million, or $1.71 per share, versus $0.9 million of net income in the same quarter of 2025. That swing looks like a profit reversal, and it's the source of the competitor headline. But $4.3 million of the $18 million in selling, general, and administrative expenses this quarter was driven by professional fees tied to the Weatherford transaction. Strip out merger costs, and the operating business produced a small profit, not a meaningful loss. The GAAP result is a bookkeeping artifact of deal-making, not an indicator of operational deterioration.

So why is the stock at $47 when the underlying business produced just $1.9 million of adjusted EBITDA on $38.4 million of revenue? That works out to an EBITDA margin of 5% for the quarter - a thin number for an energy services company. For perspective, NCS's full-year 2025 adjusted EBITDA was $26.7 million on $183.6 million of revenue, or a 15% margin. The public float at $47 per share is worth roughly $127 million. That implies a standalone enterprise value multiple of roughly 6 to 7 times trailing adjusted EBITDA. It's not expensive, but it's not fantastically undervalued either. It's a small-cap niche player trading near the blended value of the deal.

Which is the point. The deal value, on a blended basis, equals 0.463 shares of Weatherford for each NCS share, with shareholders able to elect either all stock (0.554 Weatherford shares) or a mixed cash-and-stock package. Weatherford is currently trading at $87.79. That makes the all-stock election worth approximately $48.64 per NCS share, and the blended value about $40.65. The stock is sitting at $47, essentially pricing in that most shareholders will elect all stock, with only a narrow $1.60 spread to the ceiling.

That's what has driven the rally, not an earnings renaissance.

And here's where the arbitrage gets interesting. When the deal was announced on June 1, Weatherford was priced at $103.64, implying an all-stock ceiling of roughly $57.39 per NCS share. Since then, Weatherford has fallen roughly 15%, and the NCS ceiling has come down with it to $48.64. The spread that existed at announcement - roughly $28 between NCS's pre-deal price and the all-stock value - has compressed to about $1.60. For a trade expected to close in the second half of 2026, the remaining annualized return from here is single digits, assuming the deal closes at all.

Weatherford is the larger risk. The company trades at 17.2 times trailing earnings and 7.5 times EV/EBITDA, has risen 12% year-to-date but fallen 17% over the past 120 days, and its own equity is volatile. A further drop in Weatherford's share price would directly shrink the NCS arbitrage spread. The controlling stockholder (which owns more than 50% of NCS) has already approved the deal and has little incentive to let it fail, but the transaction still requires regulatory approval and customary closing conditions. If Weatherford's stock weakens enough to pressure its own balance sheet or debt covenants, the deal terms could be renegotiated or the transaction could face delays.

From an operational perspective, the underlying NCS business deserves a separate look, even though it's about to cease existing as an independent company. The $31.3 million in cash against $7.5 million of debt - all finance lease obligations - means the balance sheet is clean. Free cash flow for the full year 2025 was $18.9 million, and even a seasonally weak first half of 2026 generated positive operating cash flow of $1.3 million in the first quarter. The asset-light model the company has touted for years genuinely does protect downside. Revenue grew in the United States, driven by its Repeat Precision product line, and the ResMetrics acquisition from July 2025 added $2.3 million of service revenue in the second quarter. Canada is the drag, with seasonal weakness and customer delays pushing activity lower year over year.

All of that is sound, small-cap energy services execution. But it doesn't matter for the current trade because the stock is no longer priced on its own cash flows. It's priced on the Weatherford ratio.

Here's the bottom line. For a long-term investor looking at NCS Multistage as a business, there is nothing to do. The company will be absorbed into Weatherford in the second half of 2026, and the current price has already captured almost all of the deal premium. For a merger arbitrage trader, the remaining spread of roughly $1.60 per share carries Weatherford equity risk and a compressed time horizon. That's a trade, not an investment. I would rate this a pass.